The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

The macular degeneration treatment market has seen remarkable growth in recent years and is poised for continued expansion. This article delves into the factors driving this growth, current trends, and future projections.

Rapid Market Growth

• Market Size and Growth Rate:
  • The market grew from $9.74 billion in 2023 to $10.99 billion in 2024.
  • This growth represents a compound annual growth rate (CAGR) of 12.8%.
• Contributing Factors:
  • Aging Population: Increasing elderly population susceptible to macular degeneration.
  • Lifestyle Changes: Rising cases due to lifestyle factors like smoking and poor diet.
  • Limited Treatment Options: Demand for new and effective treatments.
  • Rising Awareness: Greater awareness leading to early diagnosis and treatment.
  • Healthcare Infrastructure Development: Enhanced healthcare facilities supporting treatment accessibility.

View More On The Macular Degeneration Treatment Market Report 2024 – https://www.thebusinessresearchcompany.com/report/macular-degeneration-treatment-global-market-report

Future Market Projections

• Expected Market Size:
  • Projected to reach $16.99 billion by 2028.
  • Forecast CAGR of 11.5%.
• Growth Drivers:
  • Advancements in Research: New treatments and technologies being developed.
  • Increased Healthcare Expenditure: Higher spending on healthcare globally.
  • Rising Incidence Rates: Growing number of macular degeneration cases.
  • Personalized Medicine Approaches: Tailored treatments improving efficacy.
  • Global Vision Health Initiatives: Worldwide efforts to combat vision loss.

Major Trends in the Forecast Period

• Focus on Neuroprotection and Regeneration Therapies: Developing treatments that protect and regenerate retinal cells.
• Expansion of Telemedicine and Remote Monitoring: Leveraging technology for better patient management.
• Personalized Medicine Approaches: Customized treatments based on genetic and lifestyle factors.
• Investigation of Stem Cell Therapies: Researching stem cell applications for vision restoration.
• Patient-Focused Initiatives for Awareness and Education: Educating patients on disease management and prevention.

Growing Retinal Disorder Incidence Propels Market Growth

• Increasing Burden of Retinal Disorders:
  • Retinal disorders leading to vision impairment and blindness are on the rise.
  • The American Academy of Ophthalmology projects that by 2050, 7.32 million Americans will have primary open-angle glaucoma.
• Demographic Impact:
  • Highest incidence among populations aged 70 to 79 years, women, and Hispanics.

Key Players in the Market

• Major Companies:
  • Pfizer Inc., F. Hoffmann-La Roche Ltd., Allergan Inc., Bayer AG, Novartis AG, GlaxoSmithKline PLC, Regeneron Pharmaceuticals Inc., among others.

Advancements in Therapies

• Gene Therapy Innovations:
  • Genentech’s Susvimo, approved by the FDA in 2021, offers a new treatment for wet age-related macular degeneration (AMD).
  • Susvimo requires fewer treatments per year compared to traditional therapies.

Notable Acquisitions

• Novartis Acquires Arctos Medical:
  • In September 2021, Novartis acquired Arctos Medical to enhance its vision loss solutions.
  • This acquisition leverages optogenetics for developing effective therapeutics.

Market Segmentation

• By Stage of Disease:
  • Early-Stage AMD, Intermediate AMD, Late-Stage AMD
• By End User:
  • Ambulatory Surgical Centers, Ophthalmic Clinics, Hospitals
• By Route of Administration:
  • Oral, Injectable, Other Routes
• By Types:
  • Wet Macular Degeneration, Dry Macular Degeneration

Regional Insights

• North America:
  • Largest region in the market in 2023.
• Asia-Pacific:
  • Expected to be the fastest-growing region during the forecast period.

The macular degeneration treatment market is on a robust growth trajectory, driven by technological advancements, increasing healthcare expenditure, and a growing elderly population. With continued innovation and investment, the future looks promising for advancements in managing and treating macular degeneration.

Request A Sample Of The Global Macular Degeneration Treatment Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=5799&type=smp